• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

Professional Introduction to Compound with CAS No. 1929328-19-7 and Product Name: 4-bromo-2-(chloromethyl)-1-(3,4-dichlorophenoxy)benzene

The compound in question, identified by the CAS number 1929328-19-7, is a highly specialized organic molecule with the systematic name 4-bromo-2-(chloromethyl)-1-(3,4-dichlorophenoxy)benzene. This compound belongs to a class of aromatic heterocycles that have garnered significant attention in the field of pharmaceutical and agrochemical research due to their versatile structural framework and potential biological activities. The presence of multiple substituents, including bromine, chlorine, and a chloromethyl group, makes this molecule a promising candidate for further investigation into its synthetic pathways and functional applications.

In recent years, the exploration of novel aryl compounds has been a focal point in medicinal chemistry, particularly in the development of drugs targeting various diseases. The structural features of 4-bromo-2-(chloromethyl)-1-(3,4-dichlorophenoxy)benzene suggest that it may exhibit inhibitory effects on certain enzymes or receptors involved in metabolic disorders, inflammation, or cancer. The bromine atom at the 4-position and the chloromethyl group at the 2-position are particularly noteworthy, as they can serve as reactive sites for further functionalization through cross-coupling reactions or nucleophilic substitutions.

One of the most intriguing aspects of this compound is its potential role in the synthesis of more complex pharmacophores. The 3,4-dichlorophenoxy moiety provides a rigid aromatic backbone that can be modified to enhance binding affinity or selectivity. This is particularly relevant in the context of drug discovery, where subtle structural modifications can significantly alter biological activity. Recent studies have demonstrated that aryl compounds with similar substitution patterns often exhibit potent pharmacological effects, making 4-bromo-2-(chloromethyl)-1-(3,4-dichlorophenoxy)benzene a valuable scaffold for medicinal chemists.

The chloromethyl group at the 2-position is particularly interesting from a synthetic perspective. It can be easily transformed into other functional groups such as alcohols, amines, or thiols through nucleophilic addition reactions. This reactivity makes it an ideal starting material for constructing more elaborate molecular architectures. For instance, it can be coupled with boronic acids via Suzuki-Miyaura cross-coupling to introduce aryl groups at other positions, or it can undergo reaction with organolithium reagents to form new carbon-carbon bonds.

From a computational chemistry standpoint, the electronic properties of 4-bromo-2-(chloromethyl)-1-(3,4-dichlorophenoxy)benzene have been extensively studied using density functional theory (DFT) and other quantum mechanical methods. These calculations have revealed that the compound has significant electrophilic character due to the presence of multiple electron-withdrawing groups. This electrophilicity is expected to enhance its reactivity in various chemical transformations and may also contribute to its biological activity by allowing interactions with nucleophilic residues in biological targets.

The potential applications of this compound extend beyond pharmaceuticals into the realm of materials science. For example, its rigid aromatic structure and multiple substituents make it a suitable candidate for designing organic semiconductors or liquid crystals. These materials are used in various electronic devices such as organic light-emitting diodes (OLEDs), organic photovoltaics (OPVs), and liquid crystal displays (LCDs). The ability to fine-tune the electronic properties of such materials through structural modifications could lead to breakthroughs in next-generation display technologies.

In conclusion, 4-bromo-2-(chloromethyl)-1-(3,4-dichlorophenoxy)benzene represents a fascinating compound with diverse potential applications in pharmaceuticals and materials science. Its unique structural features and reactivity make it an attractive scaffold for further synthetic exploration and biological evaluation. As research in this area continues to advance, it is likely that new derivatives will be developed with enhanced properties and novel functionalities.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)